Phase I Study of BI 831266 in Patients With Advanced Solid Tumours

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

October 31, 2010

Conditions

Neoplasms

Interventions

DRUG

Arm A

Dose escalation Arm A (4 weeks)

DRUG

Arm B

Dose escalation Arm B (3 weeks)

Trial Locations (3)

1257.1.4303 Boehringer Ingelheim Investigational Site, Linz

1257.1.4302 Boehringer Ingelheim Investigational Site, Salzburg

1257.1.4301 Boehringer Ingelheim Investigational Site, Vienna